The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
103366062 10336606 2 F 20130526 20160907 20140723 20160912 EXP US-BRISTOL-MYERS SQUIBB COMPANY-20548582 BRISTOL MYERS SQUIBB 63.00 YR M Y 125.17000 KG 20160912 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
103366062 10336606 1 PS COUMADIN WARFARIN SODIUM 1 Oral 7.5 MG, QD Y 9218 7.5 MG TABLET QD
103366062 10336606 2 SS IBUPROFEN. IBUPROFEN 1 Oral 800 MG, BID 0 800 MG FILM-COATED TABLET BID
103366062 10336606 3 SS CELECOXIB. CELECOXIB 1 Oral UNK UNK, TID 0 TID
103366062 10336606 4 SS PREDNISONE. PREDNISONE 1 Oral 7.5 MG, QD 0 7.5 MG QD
103366062 10336606 5 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 20 MG, QD U 0 20 MG QD
103366062 10336606 6 C VYTORIN EZETIMIBESIMVASTATIN 1 Oral ONGOING U 0
103366062 10336606 7 C CAPTOPRIL. CAPTOPRIL 1 Oral 25 MG, QD U 0 25 MG QD
103366062 10336606 8 C NOVOLIN INSULIN HUMAN 1 Subcutaneous BEFORE BEDTIME U 0 50 IU QD
103366062 10336606 9 C METFORMIN HYDROCHLORIDE. METFORMIN HYDROCHLORIDE 1 Oral 1000 MG, QD U 0 1000 MG QD
103366062 10336606 10 C AMLODIPINE AMLODIPINE BESYLATE 1 Oral 10 MG, QD U 0 10 MG QD
103366062 10336606 11 C FOLIC ACID. FOLIC ACID 1 Oral 1 MG, QD U 0 1 MG QD
103366062 10336606 12 C OMEPRAZOL E OMEPRAZOLE 1 Oral 20 MG, QD U 0 20 MG QD
103366062 10336606 13 C METHOTREXATE. METHOTREXATE 1 Oral 2.5 MG, UNK U 0 2.5 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
103366062 10336606 1 Anticoagulant therapy
103366062 10336606 2 Osteoarthritis
103366062 10336606 3 Osteoarthritis
103366062 10336606 4 Rheumatoid arthritis
103366062 10336606 5 Prophylaxis
103366062 10336606 6 Dyslipidaemia
103366062 10336606 7 Hypertension
103366062 10336606 8 Type 2 diabetes mellitus
103366062 10336606 9 Type 2 diabetes mellitus
103366062 10336606 10 Hypertension
103366062 10336606 11 Nutritional supplementation
103366062 10336606 12 Gastrooesophageal reflux disease
103366062 10336606 13 Rheumatoid arthritis

Outcome of event

Event ID CASEID OUTC COD
103366062 10336606 HO
103366062 10336606 OT
103366062 10336606 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
103366062 10336606 Gastrointestinal haemorrhage

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
103366062 10336606 1 2008 20130528 0
103366062 10336606 2 20120308 0
103366062 10336606 3 20111031 20120105 0
103366062 10336606 4 201305 0
103366062 10336606 5 20111031 20120105 0
103366062 10336606 6 2008 0
103366062 10336606 7 2008 0
103366062 10336606 8 20120511 0
103366062 10336606 9 2008 0
103366062 10336606 10 2008 0
103366062 10336606 11 20120521 0
103366062 10336606 12 20120413 0
103366062 10336606 13 20120730 0